Discover Q2 2025 highlights from Royalty Pharma (RPRX): double-digit growth, raised guidance, a $2B partnership, efficient cost structure, & ...

Maven Capital Partners has sold UAP, a designer and supplier of door and window hardware, to global security and access ...

The royalty aggregator’s proposed deals for HilleVax and Lava add to a pattern of “zombie” biotech buyouts this year as the ...

NEW YORK (Reuters) -KKR executives said strong momentum in their business gave them confidence on Thursday of beating ...

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.

Q2 2025 Earnings Call Transcript July 31, 2025 KKR & Co. Inc. beats earnings expectations. Reported EPS is $1.18, ...

Q2 2025 Management View Co-CEO Scott C. Nuttall highlighted the company's strong performance, stating that fee-related earnings per share reached $0.98, total operating earnings were $1.33 per share, ...

Investment giant KKR reported a 9% rise in adjusted net income for the second quarter on Thursday, bolstered by an ...